Joanne Borg-Stein

Joanne Borg-Stein

Auto-generated profile, based on publicly available information

Joanne Borg-Stein

J. Borg-Stein, MD, Harvard Medical School, Boston, and Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Charlestown, Massachusetts

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Clinical Journal of Sport Medicine
Verified
Journal Article
Closed access
JFJonathan T. Do Finnoff
Jonathan T. Do Finnoff
TATariq M. Do Awan
Tariq M. Do Awan
JBJoanne Borg-Stein
Joanne Borg-Stein
KHKimberly G Harmon
Kimberly G Harmon
DHDaniel C Herman
Daniel C Herman
SSShane A. Shapiro
Shane A. Shapiro
Many sports medicine physicians are currently considering introducing regenerative medicine into their practice. Regenerative medicine and the subclassification of orthobiologics are a complicated topic and have produced widely varying opinions. Although there is concern by government regulators, clinicians, scientists, patient advocacy organizations, and the media regarding the use of regenerative medicine products, there is also excitement about the potential benefits with growing evidence that certain regenerative medicine products are safe and potentially efficacious in treating musculoskeletal conditions. Sports medicine physicians would benefit from decision-making guidance about whether to introduce orthobiologics into their practice and how to do it responsibly. The purpose of this position statement is to provide sports medicine physicians with information regarding regenerative medicine terminology, a brief review of basic science and clinical studies within the subclassification of orthobiologics, regulatory considerations, and best practices for introducing regenerative medicine into clinical practice. This information will help sports medicine physicians make informed and responsible decisions about the role of regenerative medicine and orthobiologics in their practice.

18 October 2022 in Physical Medicine and Rehabilitation Clinics of North America
Verified
Journal Article
Closed access
CHConnie Hsu
Connie Hsu
KVKevin Vu
Kevin Vu
JBJoanne Borg-Stein
Joanne Borg-Stein

1 June 2004 in Seminars in Pain Medicine
Verified
Journal Article
Closed access
JBJoanne Borg-Stein
Joanne Borg-Stein

26 March 2021 in Military Medicine
Verified
Journal Article
Open access
PDF file
HSHannah K Steere
Hannah K Steere
SDStephanie DeLuca
Stephanie DeLuca
JBJoanne Borg-Stein
Joanne Borg-Stein
GMGerard A Malanga
Gerard A Malanga
Adam S. TenfordeAdam S. Tenforde
Adam S. Tenforde
Introduction: Extracorporeal shockwave therapy (ESWT) has a wide variety of clinical applications ranging from urology to orthopedics. Extracorporeal shockwave therapy is of particular interest to military medicine in the treatment of diverse musculoskeletal injuries, including recalcitrant tendinopathy. Much of the evidence for ESWT is from studies in the civilian population, including athletes. A few investigations have been conducted within military personnel. Musculoskeletal conditions within military personnel may contribute to pain and physical limitations. Optimal functional outcomes could be achieved through ESWT. The purpose of this narrative review is to summarize the current evidence on the efficacy of ESWT the in management of lower extremity musculoskeletal injuries in the military. Further, we explore the relative efficacy of ESWT compared to regenerative medicine procedures, including studies with treatment using platelet-rich plasma. Materials and Methods: A literature review was performed in April 2020 to identify studies evaluating the use of ESWT for lower extremity conditions commonly observed in military personnel, including plantar fasciitis, Achilles tendinopathy, patellar tendinopathy, medial tibial stress syndrome, and knee arthritis. The literature search was completed by two researchers independently, using PubMed and Embase databases and same search terms. Disagreements were adjudicated by a senior author. Due to the paucity of relevant search results, the search term parameters were expanded to incorporate active participants. Results: Two studies evaluated the use of ESWT in a military population for lower extremity injuries. This included a randomized control trial in active military with medial tibial stress syndrome and an unblinded retrospective study for the chronic plantar fasciitis condition. Both studies in the military had favorable outcomes in the use of ESWT compared to other treatment arms. The remaining studies predominantly included athletes. Although heterogeneity on the quality of the studies may prevent meta-analysis and limit the generalization of the findings, the majority of studies demonstrated an improvement in pain and return to activity using ESWT. Two studies using platelet-rich plasma as a treatment arm identified similar short-term outcomes compared to ESWT for Achilles tendinopathy and patellar tendinopathy. Conclusion: Our findings suggest that ESWT is a safe and well-tolerated intervention with positive outcomes for lower extremity conditions commonly seen in the military. The few studies comparing ESWT to PRP suggest regenerative benefits similar to orthobiologics in the shorter term. More robust quality designed research may enable the evaluation of ESWT efficacy within the military population. In summary, the use of ESWT may provide pain reduction and improved function in active populations with lower extremity musculoskeletal injuries. Further research in the military is needed to evaluate shockwave efficacy in order to advance musculoskeletal care and improve outcomes.

14 July 2006 in Journal of Back and Musculoskeletal Rehabilitation
Verified
Journal Article
Closed access
PDF file
JBJoanne Borg-Stein
Joanne Borg-Stein
SMS. Ali Mostoufi
S. Ali Mostoufi
RHRonald Hirschberg
Ronald Hirschberg
Anterior chest wall pain resulting from an athletic injury has a broad differential diagnosis including muscular strain, partial or complete pectoralis tear, avulsion of the pectoralis tendon, rotator cuff injury and referred pain. Rupture of the pec

1 January 1994
Verified
Book Chapter
Closed access
JMJonathan R. Moldover
Jonathan R. Moldover
JBJoanne Borg-Stein
Joanne Borg-Stein